Stock Taper 
GMED
$80.25
▼ DOWN 1.38% (-1.12)
KEY STATISTICS
Market Cap$10.98 B
52w High$101.40
52w Low$54.15
Dividend Yield—
Frequency—
P/E18.07
Volume251.03K
Shares Out.134.86M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Keith W. Pfeil
COMPENSATION 2026
Salary$284,616
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$25,678
Total$5,316,939
ABOUT
SECTOR
Healthcare
WENT PUBLIC
August 3, 2012
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6,000
PRICE TARGET
Target High$117.00
Target Low$80.00
Target Median$100.00
Target Consensus$98.88
UPCOMING EARNINGS
DateNov 5, 2026
DayThursday
Rev. Est.$792.25M
NOV
5
THU
PRICE
$80.25 ▼ DOWN 1.38% (−$1.12)About Globus Medical, Inc.
https://www.globusmedical.com ↗Globus Medical develops and markets innovative medical devices for musculoskeletal disorders, including spine, trauma, joint, and regenerative products globally, headquartered in Audubon, PA.
INDUSTRY
Medical - Devices
A PRODUCT GLOBUS MEDICAL, INC. IS KNOWN FOR
ExcelsiusGPS Robotic Navigation Platform
ExcelsiusGPS is a robotic navigation platform that provides real-time guidance for surgeons during spine and cranial procedures. It is designed to improve the accuracy of implant and screw placement, enabling less invasive surgical techniques.
Revenue by Products
| Icon | PRODUCT | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|---|
 | Spine | $610.34M | $575.93M ▼ | $710.18M ▲ | $741.01M ▲ |
 | Emerging Technology | $46.95M | $22.19M ▼ | $35.16M ▲ | $28.04M ▼ |
Revenue by Geography
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | UNITED STATES | $617.63M | $665.32M ▲ | $604.89M ▼ | $619.11M ▲ |
 | NonUS | $151.41M | — | — | — |
ETFS HOLDING THIS STOCK
ETFS HOLDING
239
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
51.97%
HOLDERS
878
TOP 12 OF 878 · RANKED BY POSITION SIZE
Blackrock, Inc.
Vanguard Group Inc
Blackrock Inc.
Janus Henderson Group Plc
Blackrock Fund Advisors
Invesco Ltd.
Kayne Anderson Rudnick Investment Management LLC
State Street Corp
Jpmorgan Chase & Co
Sculptor Capital LP
Burgundy Asset Management Ltd.
Bank Of Montreal /Can/
RATINGS SNAPSHOT
Overall rating: A
Discounted Cash Flow5
Return On Equity4
Return On Assets5
Debt To Equity4
Price To Earnings2
Price To Book3
Overall Score4
TRADES BY CONGRESS
HOUSE TRADES
Lisa McClain
Sale (Full)
2025-07-10
Josh Gottheimer
Sale (Partial)
2025-04-09
Daniel Goldman
Sale (Full)
2023-03-06
Ro Khanna
Sale
2022-08-23
INSIDER TRADES
★
DIRECTOR
ZARRILLI STEPHEN T
Purchase · 25.0K shares
2026-08-18
★
DIRECTOR
ZARRILLI STEPHEN T
Sale · 25.0K shares
2026-08-18
★
DIRECTOR
Davidar David D
Sale · 2.5K shares
2026-07-27
★
DIRECTOR
Davidar David D
Purchase · 25.0K shares
2026-06-05
MOST RECENT ANALYST GRADES
GRADE SUMMARY
OVERWEIGHT 4
BUY 4
OUTPERFORM 1
HOLD 1
10 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 PEN | $322.94 | COMPARE |
 ALGN | $158.80 | COMPARE |
 DVA | $176.45 | COMPARE |
 BIO | $385.67 | COMPARE |
 MOH | $198.70 | COMPARE |
 HSIC | $89.48 | COMPARE |
 ATR | $131.78 | COMPARE |
 HQY | $95.78 | COMPARE |